PTP-1B inhibitors (Metabasis)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NamePTP-1B inhibitors (Metabasis)
Drug Alias NamePTB 1B inhibitors (Structural Bioinformatics)PTP-1B inhibitors (Cengent)protein tyrosine phosphatase 1B inhibitors (Cengent)protein tyrosine phosphatase 1B inhibitors (Structural Bioinformatics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInsulin sensitizersProtein tyrosine phosphatase inhibitors
TargetsProtein tyrosine phosphatase
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCengent Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCengent Therapeutics IncMetabasis Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsObesityDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A